<!DOCTYPE html>
<html lang="en" data-theme="light">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Chapter 14: Molecular Oncology - Molecular Diagnostics</title>
    
    <!-- Preconnect for performance -->
    <link rel="preconnect" href="https://fonts.googleapis.com">
    <link rel="preconnect" href="https://fonts.gstatic.com" crossorigin>
    
    <!-- Google Fonts -->
    <link href="https://fonts.googleapis.com/css2?family=Inter:wght@400;500;600;700&family=Source+Serif+4:opsz,wght@8..60,400;8..60,600&display=swap" rel="stylesheet">
    
    <!-- KaTeX for Math rendering -->
    <link rel="stylesheet" href="https://cdn.jsdelivr.net/npm/katex@0.16.9/dist/katex.min.css">
    <script defer src="https://cdn.jsdelivr.net/npm/katex@0.16.9/dist/katex.min.js"></script>
    <script defer src="https://cdn.jsdelivr.net/npm/katex@0.16.9/dist/contrib/auto-render.min.js" onload="renderMathInElement(document.body, {
        delimiters: [
            {left: '$$', right: '$$', display: true},
            {left: '$', right: '$', display: false}
        ]
    });"></script>
    
    <!-- Main Stylesheet -->
    <link rel="stylesheet" href="../styles/main.css">
</head>
<body>
    <a href="#main-content" class="skip-link">Skip to main content</a>
    
    <button class="theme-toggle" id="theme-toggle" aria-label="Toggle dark mode">
        <span class="theme-toggle-icon light-icon">‚òÄÔ∏è</span>
        <span class="theme-toggle-icon dark-icon">üåô</span>
    </button>

    <!-- Reading Progress Bar -->
    <div class="reading-progress-container">
        <div class="reading-progress-bar" id="reading-progress"></div>
    </div>

    <div class="page-wrapper">
        <!-- Floating Table of Contents -->
        <nav class="floating-toc" id="floating-toc">
            <div class="floating-toc-header">
                <span>üìë</span> Table of Contents
            </div>
            <ul class="floating-toc-list">
                <!-- Links will be populated by JS -->
            </ul>
        </nav>

        <div class="container">
            <article class="document-article">
                
                <!-- TOP NAVIGATION -->
                <nav class="document-nav" role="navigation" aria-label="Document Navigation">
                    <div class="nav-links">
                        <a href="chapter-13-inherited-diseases.html" class="nav-button nav-button--previous">
                            <span class="nav-icon">‚Üê</span>
                            <span class="nav-text">Previous</span>
                        </a>
                        
                        <a href="../index.html" class="nav-button">
                            <span class="nav-icon">üè†</span>
                            <span class="nav-text">Home</span>
                        </a>
                        
                        <a href="chapter-15-tissue-typing.html" class="nav-button nav-button--next">
                            <span class="nav-text">Next</span>
                            <span class="nav-icon">‚Üí</span>
                        </a>
                    </div>
                    <div class="document-progress">
                        <div class="progress-bar" aria-hidden="true">
                            <div class="progress-fill" style="width: 87.5%;"></div>
                        </div>
                        <span class="progress-text">Topic 14 of 16</span>
                    </div>
                </nav>

                <!-- Document Header -->
                <header class="document-header">
                    <div class="header-badge">
                        <span>üß¨</span>
                        <span>Topic 14</span>
                    </div>
                    <h1 class="document-title">Molecular Oncology</h1>
                    <div class="title-meta">
                        <div class="meta-item">
                            <span>üìö</span>
                            <span>Techniques in the Clinical Lab</span>
                        </div>
                        <div class="meta-item">
                            <span>‚è±Ô∏è</span>
                            <span>45 min read</span>
                        </div>
                    </div>
                </header>

                <main id="main-content" class="content-wrapper">
                    
                    <!-- Introduction -->
                    <section class="content-section" id="introduction">
                        <div class="content-card">
                            <p>Molecular diagnostics has revolutionized the diagnosis, prognosis, and treatment of cancer. By analyzing the genetic alterations within tumors, clinicians can classify neoplasms more accurately, select targeted therapies, and monitor disease progression. This chapter explores the molecular basis of cancer and the specific molecular targets used in the clinical laboratory.</p>
                        </div>
                    </section>

                    <!-- Classification of Neoplasms -->
                    <section class="content-section" id="classification">
                        <div class="section-header">
                            <div class="section-number">01</div>
                            <h2 class="section-title">
                                <span class="title-icon">üìÇ</span>
                                Classification of Neoplasms
                            </h2>
                        </div>

                        <div class="content-card">
                            <p>Neoplasms are classified based on their tissue of origin and their potential for invasion.</p>
                            <ul class="enhanced-list">
                                <li class="list-item">
                                    <span class="list-marker"></span>
                                    <span class="list-content"><strong>Carcinomas:</strong> Derived from epithelial tissue (e.g., breast, lung, colon).</span>
                                </li>
                                <li class="list-item">
                                    <span class="list-marker"></span>
                                    <span class="list-content"><strong>Sarcomas:</strong> Derived from connective tissue (e.g., bone, cartilage, muscle).</span>
                                </li>
                                <li class="list-item">
                                    <span class="list-marker"></span>
                                    <span class="list-content"><strong>Hematopoietic Neoplasms:</strong> Derived from blood-forming tissues (e.g., leukemias, lymphomas).</span>
                                </li>
                            </ul>
                        </div>
                    </section>

                    <!-- Molecular Basis of Cancer -->
                    <section class="content-section" id="molecular-basis">
                        <div class="section-header">
                            <div class="section-number">02</div>
                            <h2 class="section-title">
                                <span class="title-icon">üß¨</span>
                                Molecular Basis of Cancer
                            </h2>
                        </div>

                        <div class="content-card">
                            <p>Cancer is a genetic disease caused by the accumulation of mutations in genes that control cell growth and division. These mutations typically affect two classes of genes:</p>

                            <div class="grid grid-2">
                                <div class="grid-item">
                                    <h4>Oncogenes</h4>
                                    <p>Mutated versions of normal genes (proto-oncogenes) that promote cell growth. Mutations are typically <strong>gain-of-function</strong> and dominant. Examples: <em>KRAS</em>, <em>HER2</em>, <em>EGFR</em>.</p>
                                </div>
                                <div class="grid-item">
                                    <h4>Tumor Suppressor Genes</h4>
                                    <p>Genes that normally inhibit cell growth or repair DNA. Mutations are typically <strong>loss-of-function</strong> and recessive (require loss of both alleles). Examples: <em>TP53</em>, <em>RB1</em>, <em>BRCA1</em>.</p>
                                </div>
                            </div>
                        </div>
                    </section>

                    <!-- Analytical Targets -->
                    <section class="content-section" id="targets">
                        <div class="section-header">
                            <div class="section-number">03</div>
                            <h2 class="section-title">
                                <span class="title-icon">üéØ</span>
                                Analytical Targets of Molecular Testing
                            </h2>
                        </div>

                        <div class="content-card">
                            <h3>Gene and Chromosomal Mutations in Solid Tumors</h3>
                            <p>Specific mutations in solid tumors serve as diagnostic markers and targets for therapy.</p>
                            <ul class="enhanced-list">
                                <li class="list-item">
                                    <span class="list-marker"></span>
                                    <span class="list-content"><strong>HER2/neu (ERBB2):</strong> Amplification in breast cancer predicts response to Trastuzumab (Herceptin). Detection by FISH or IHC.</span>
                                </li>
                                <li class="list-item">
                                    <span class="list-marker"></span>
                                    <span class="list-content"><strong>EGFR:</strong> Mutations in the Epidermal Growth Factor Receptor gene in lung cancer predict response to tyrosine kinase inhibitors (TKIs).</span>
                                </li>
                                <li class="list-item">
                                    <span class="list-marker"></span>
                                    <span class="list-content"><strong>KRAS:</strong> Mutations in colorectal cancer indicate resistance to anti-EGFR therapies (e.g., Cetuximab).</span>
                                </li>
                                <li class="list-item">
                                    <span class="list-marker"></span>
                                    <span class="list-content"><strong>BRAF:</strong> The V600E mutation in melanoma is a target for specific inhibitors (Vemurafenib).</span>
                                </li>
                            </ul>

                            <h3>Microsatellite Instability (MSI)</h3>
                            <p>Microsatellites are short repetitive DNA sequences. In cells with defective <strong>Mismatch Repair (MMR)</strong> systems, these sequences change length (instability). MSI is a hallmark of Hereditary Non-Polyposis Colorectal Cancer (HNPCC or Lynch Syndrome).</p>
                            
                            <p><strong>Detection:</strong> PCR amplification of specific microsatellite markers (Bethesda panel). Instability is seen as extra peaks or shifts in fragment size on capillary electrophoresis.</p>

                            <figure class="content-figure" data-lightbox="true">
                                <div class="figure-image-wrapper">
                                    <img src="../assets/images/image-20251222-219f4e51.jpeg" alt="Microsatellite Instability" class="figure-image"> <!-- Reusing generic electropherogram image concept for illustration -->
                                    <div class="figure-overlay">
                                        <span class="overlay-icon">üîç</span>
                                        <span class="overlay-text">Click to enlarge</span>
                                    </div>
                                </div>
                                <figcaption class="figure-caption">Figure 14-1 Microsatellite Instability (MSI) analysis. The presence of additional peaks indicates instability in the number of repeats due to mismatch repair defects.</figcaption>
                            </figure>

                            <h3>Loss of Heterozygosity (LOH)</h3>
                            <p>LOH refers to the loss of one allele of a gene, often a tumor suppressor gene. This can occur via deletion or mitotic recombination. LOH analysis compares normal tissue DNA to tumor DNA using polymorphic markers (STRs or SNPs) flanking the gene of interest.</p>
                        </div>
                    </section>

                    <!-- Gene Rearrangements -->
                    <section class="content-section" id="rearrangements">
                        <div class="section-header">
                            <div class="section-number">04</div>
                            <h2 class="section-title">
                                <span class="title-icon">ü©∏</span>
                                Gene Rearrangements in Leukemia and Lymphoma
                            </h2>
                        </div>

                        <div class="content-card">
                            <h3>V(D)J Recombination and Clonality</h3>
                            <p>Normal B and T lymphocytes undergo rearrangement of their antigen receptor genes (Immunoglobulin heavy/light chains and T-cell receptors) to generate diversity. This process involves the random joining of Variable (V), Diversity (D), and Joining (J) segments.</p>
                            
                            <p><strong>Clonality Detection:</strong> In a malignancy (leukemia/lymphoma), all cells originate from a single clone and therefore share the <em>same</em> specific gene rearrangement. In a reactive (benign) condition, cells are polyclonal (many different rearrangements). PCR or Southern blot can detect the presence of a dominant clonal population.</p>

                            <div class="callout callout--note">
                                <div class="callout-header">
                                    <span class="callout-icon">üí°</span>
                                    <h4 class="callout-title">Methodology</h4>
                                </div>
                                <div class="callout-content">
                                    <p>PCR using consensus primers flanking the V-J or V-D-J junction amplifies the rearranged region. A <strong>clonal</strong> sample produces a sharp single band (or peak). A <strong>polyclonal</strong> sample produces a smear (or broad distribution) because many different sized fragments are amplified.</p>
                                </div>
                            </div>

                            <h3>Translocations in Hematological Malignancies</h3>
                            <p>Specific chromosomal translocations are hallmarks of many hematological cancers. They often create fusion genes that drive tumorigenesis.</p>

                            <div class="table-wrapper">
                                <div class="table-header">
                                    <span class="table-icon">üìä</span>
                                    <span class="table-title">Table 14.1 Common Translocations in Hematological Malignancies</span>
                                </div>
                                <div class="table-container">
                                    <table class="content-table">
                                        <thead>
                                            <tr>
                                                <th>Translocation</th>
                                                <th>Genes Involved</th>
                                                <th>Disease Association</th>
                                                <th>Molecular Effect</th>
                                            </tr>
                                        </thead>
                                        <tbody>
                                            <tr><td><strong>t(9;22)</strong></td><td><em>BCR-ABL1</em></td><td>CML, ALL</td><td>Constitutively active tyrosine kinase (Philadelphia chromosome)</td></tr>
                                            <tr><td><strong>t(15;17)</strong></td><td><em>PML-RARA</em></td><td>APL (AML M3)</td><td>Block in differentiation; responds to ATRA therapy</td></tr>
                                            <tr><td><strong>t(14;18)</strong></td><td><em>BCL2-IGH</em></td><td>Follicular Lymphoma</td><td>Overexpression of BCL2 (anti-apoptotic)</td></tr>
                                            <tr><td><strong>t(8;14)</strong></td><td><em>MYC-IGH</em></td><td>Burkitt Lymphoma</td><td>Overexpression of MYC (cell proliferation)</td></tr>
                                            <tr><td><strong>t(11;14)</strong></td><td><em>CCND1-IGH</em></td><td>Mantle Cell Lymphoma</td><td>Overexpression of Cyclin D1</td></tr>
                                        </tbody>
                                    </table>
                                </div>
                            </div>

                            <figure class="content-figure" data-lightbox="true">
                                <div class="figure-image-wrapper">
                                    <img src="../assets/images/image-20251222-3ce846ca.jpeg" alt="FISH Translocation" class="figure-image">
                                    <div class="figure-overlay">
                                        <span class="overlay-icon">üîç</span>
                                        <span class="overlay-text">Click to enlarge</span>
                                    </div>
                                </div>
                                <figcaption class="figure-caption">Figure 14-2 Detection of t(9;22) by FISH. The fusion of the red (BCR) and green (ABL) signals creates a yellow fusion signal, indicating the presence of the Philadelphia chromosome.</figcaption>
                            </figure>

                            <p><strong>Methods of Detection:</strong>
                            <ul class="enhanced-list">
                                <li class="list-item"><strong>Karyotyping:</strong> Visualizes the entire chromosome set but has lower resolution.</li>
                                <li class="list-item"><strong>FISH:</strong> Uses fluorescent probes to detect specific translocations in interphase or metaphase cells.</li>
                                <li class="list-item"><strong>RT-PCR:</strong> Amplifies the fusion mRNA transcript (e.g., BCR-ABL). Highly sensitive and useful for monitoring <strong>Minimal Residual Disease (MRD)</strong>.</li>
                            </ul>
                            </p>
                        </div>
                    </section>

                    <!-- Key Points -->
                    <aside class="key-points-section" role="region" aria-labelledby="key-points-title">
                        <div class="key-points-wrapper">
                            <div class="key-points-header">
                                <span class="key-points-icon">‚≠ê</span>
                                <h3 id="key-points-title" class="key-points-title">Key Points</h3>
                            </div>
                            <ul class="key-points-list">
                                <li class="key-point-item">
                                    <span class="point-marker">‚úì</span>
                                    <p><strong>Cancer results from mutations in oncogenes (gain of function) and tumor suppressor genes (loss of function).</strong></p>
                                </li>
                                <li class="key-point-item">
                                    <span class="point-marker">‚úì</span>
                                    <p><strong>Solid tumor markers like HER2, EGFR, and KRAS guide targeted therapy decisions.</strong></p>
                                </li>
                                <li class="key-point-item">
                                    <span class="point-marker">‚úì</span>
                                    <p><strong>Microsatellite Instability (MSI) indicates defects in mismatch repair genes and is a screen for Lynch syndrome.</strong></p>
                                </li>
                                <li class="key-point-item">
                                    <span class="point-marker">‚úì</span>
                                    <p><strong>Clonality in leukemias and lymphomas is detected by analyzing V(D)J rearrangements using PCR.</strong></p>
                                </li>
                                <li class="key-point-item">
                                    <span class="point-marker">‚úì</span>
                                    <p><strong>Chromosomal translocations (e.g., BCR-ABL) serve as diagnostic markers and targets for therapy (e.g., Imatinib).</strong></p>
                                </li>
                            </ul>
                        </div>
                    </aside>

                    <!-- Study Questions -->
                    <section class="content-section" id="study-questions">
                        <div class="section-header">
                            <div class="section-number">?</div>
                            <h2 class="section-title">Study Questions</h2>
                        </div>
                        <div class="content-card">
                            <ol class="enhanced-list">
                                <li class="list-item">
                                    <span class="list-marker"></span>
                                    <span class="list-content">What is the difference between an oncogene and a tumor suppressor gene? Give an example of each.</span>
                                </li>
                                <li class="list-item">
                                    <span class="list-marker"></span>
                                    <span class="list-content">How does the detection of a monoclonal B-cell population assist in the diagnosis of lymphoma?</span>
                                </li>
                                <li class="list-item">
                                    <span class="list-marker"></span>
                                    <span class="list-content">A patient with CML is treated with Gleevec (Imatinib). What molecular marker is monitored to assess response to therapy?</span>
                                </li>
                                <li class="list-item">
                                    <span class="list-marker"></span>
                                    <span class="list-content">Describe the phenomenon of Microsatellite Instability and its clinical significance.</span>
                                </li>
                                <li class="list-item">
                                    <span class="list-marker"></span>
                                    <span class="list-content">Which translocation is associated with Follicular Lymphoma?</span>
                                </li>
                            </ol>
                        </div>
                    </section>

                </main>

                <!-- BOTTOM NAVIGATION -->
                <nav class="document-nav" role="navigation" aria-label="Document Navigation">
                    <div class="nav-links">
                        <a href="chapter-13-inherited-diseases.html" class="nav-button nav-button--previous">
                            <span class="nav-icon">‚Üê</span>
                            <span class="nav-text">Previous</span>
                        </a>
                        
                        <a href="../index.html" class="nav-button">
                            <span class="nav-icon">üè†</span>
                            <span class="nav-text">Home</span>
                        </a>
                        
                        <a href="chapter-15-tissue-typing.html" class="nav-button nav-button--next">
                            <span class="nav-text">Next</span>
                            <span class="nav-icon">‚Üí</span>
                        </a>
                    </div>
                    <div class="document-progress">
                        <div class="progress-bar" aria-hidden="true">
                            <div class="progress-fill" style="width: 87.5%;"></div>
                        </div>
                        <span class="progress-text">Topic 14 of 16</span>
                    </div>
                </nav>

            </article>
        </div>
    </div>

    <!-- Lightbox Modal -->
    <div id="lightbox" class="lightbox-modal" hidden aria-hidden="true" role="dialog" aria-label="Image viewer">
        <div class="lightbox-backdrop"></div>
        <div class="lightbox-content">
            <button class="lightbox-close" aria-label="Close image viewer">√ó</button>
            <img class="lightbox-image" src="" alt="">
            <p class="lightbox-caption"></p>
        </div>
    </div>

    <!-- Scripts -->
    <script src="../js/theme.js"></script>
    <script src="../js/navigation.js"></script>
    <script src="../js/interactions.js"></script>
</body>
</html>